What top creators are saying about Ovid Therapeutics Inc.(OVID)
Biopharmaceutical company with an upcoming catalyst for drug OV329
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Ovid Therapeutics Inc. in the last 30 days yet.
Top creators covering Ovid Therapeutics Inc. (OVID)
The 1 sources with the most insights about Ovid Therapeutics Inc. on Kazuha.
Latest insights about Ovid Therapeutics Inc. (OVID)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, September 29, 2025
Viewed as a 'crappy drug company' with an upcoming binary event for its drug OV329 that is expected to yield meaningless data, leading to a very low confidence outlook.
Monday, September 29, 2025
Viewed as a 'crappy drug company' with an upcoming binary event for its drug OV329 that is expected to yield meaningless data, leading to a very low confidence outlook.
Discussed alongside Ovid Therapeutics Inc. (OVID)
Other assets that creators frequently mention in the same content as Ovid Therapeutics Inc..
Frequently asked
Which podcasters and creators cover Ovid Therapeutics Inc. (OVID) the most?
The most active sources covering Ovid Therapeutics Inc. (OVID) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Ovid Therapeutics Inc. (OVID) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Ovid Therapeutics Inc. (OVID) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Ovid Therapeutics Inc. (OVID)?
Creators covering Ovid Therapeutics Inc. (OVID) most frequently also discuss LLY, IBM, OPEN, HSBC. See the "Discussed alongside" section above for full asset pages.